http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://go.drugbank.com/drugs/DB00181 DB00181

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0002046 MONDO_0002046

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RAZRqDsdRC...#cohort cohort

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/28658981/ pubmed.ncbi.nlm.nih.gov/28658981

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

Only a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the latter is licensed for reduction of alcohol consumption only), the putative glutamate receptor antagonist acamprosate and the aldehyde dehydrogenase inhibitor disulfiram. It also covers off-label medications of interest, including topiramate, gabapentin, ondansetron, varenicline, baclofen, sodium oxybate and antidepressants.

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

0000-0002-7641-6446

2021-08-25T17:56:26.456Z

http://purl.org/np/RAZRqDsdRC... RAZRqDsdRC

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-08-25T17:56:26.456Z